To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Clearlake’s Symplr returns to market, all options on the table
Three banks advise the healthcare-focused GRC software company, which is expected to command a more-than $4bn valuation in a potential transaction.
